Signos raised $20 million to tackle weight loss with CGMs and data
Weight loss has always been big business, but it's exploded of late due to for Ozempic, Wegovy and other new diabetes and obesity drugs. In the first half of 2023, sales of Ozempic and Wegovy rose by 58% and 363%, respectively. That's after...
2023-10-25 21:53:58